Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eve vs RxSpan MD

By GLP-1 ScorecardUpdated

EveFactor scores not reassessed.
Site position #206

Lower score

RxSpan MD
Site position #4

Higher score

Score comparison

RxSpan MD has the higher recorded score — 84.3/100 to 66.3/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Before you choose

Neither seller publishes a medication price, so the Eve review and the RxSpan MD review are where to see what each one does disclose about fees, renewal and cancellation. Ask both for a written total, including any membership, before deciding.

If neither one fits, Eve vs Semaglutide Online and Evernow vs RxSpan MD compare each of them with another graded program, and the list of alternatives to Eve ranks the programs closest to Eve on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRxSpan MD +31
55
86
Dose & formulationRxSpan MD +1
88
89
Clinical oversightRxSpan MD +9
79
88
Labs & monitoringRxSpan MD +31
52
83
FulfillmentRxSpan MD +22
67
89
Contract termsRxSpan MD +12
41
53
Eve · top barRxSpan MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEveRxSpan MD
WeighScore66.3/10084.3/100
GradeCB
Site position#206#4
SemaglutideCurrent price not verifiedCurrent compounded quote unconfirmed
TirzepatideCurrent price not verifiedCurrent compounded quote unconfirmed
CoverageConfirm coverage for your stateConfirm treatment availability during intake
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eve

Site position #206 · C

Factor scores not reassessed.

Strengths

  • Homepage lists Wegovy, Ozempic and Mounjaro
  • Terms identify Eve Health, Inc. and describe third-party care

What to consider

  • Current compounded prices and plan-specific cancellation terms remain unverified
RxSpan MD

Site position #4 · B

Strengths

  • Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
  • Public terms describe independent healthcare providers
  • Homepage describes messaging and care-team appointments

What to consider

  • Homepage advertises compounded plans that the current catalog did not substantiate
  • Current oral GLP-1 availability is unconfirmed
  • Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
  • Public terms do not establish unused prepaid-treatment refund amounts

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard